Use of Surfactant in Very Low Birth Weight Infants with Severe Respiratory Distress Syndrome: Initial Experience and Problems

  • T. A. Clarke
  • S. Gormally
  • A. Bergin
  • M. King
  • T. G. Matthews
Conference paper

Abstract

It is now accepted that surfactant therapy is effective in prevention and amelioration of the respiratory distress syndrome (Avery et al. 1986). However, the question whether to await establishment of RDS or treat some or all infants at risk prophylactically at birth remains to be answered. The approach ultimately adopted may depend on the risk of mortality and morbidity from RDS in a particular perinatal unit and the efficacy of surfactant in routine clinical practice.

Keywords

Surfactant Catheter Dopamine Indomethacin Pneumothorax 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Avery ME, Taeusch HW, Floros J (1986) Surfactant replacement. N Engl J Med 315: 825–826PubMedCrossRefGoogle Scholar
  2. Clarke TA, McKenna PJ, Matthews TG (1987) Factors associated with neonatal deaths in very low birth weight infants. Ir J Med Sci 156: 211–214PubMedCrossRefGoogle Scholar
  3. Clements JA, Platzker ACG, Tierney DF et al (1972) Assessment of the risk of the respiratory distress syndrome by a rapid test for surfactant in amniotic fluid. N Engl J Med 286: 1077PubMedCrossRefGoogle Scholar
  4. Fujiwara T, Maeta H, Chida S et al (1980) Artificial surfactant therapy in hyaline membrane disease. Lancet 1: 55–59PubMedCrossRefGoogle Scholar
  5. Gitlin JD, Soll RF, Parad RB et al (1987) Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease. Pediatrics 79: 31–37PubMedGoogle Scholar
  6. Matthews TG, Clarke TA (1987) Very low birth weight infants — survival related to obstetric and neonatal variables. Rotunda Hospital Dublin; Clinical Report 1986, pp 88–90Google Scholar
  7. Merritt TA, Hallmann M, Bloom BT et al (1986) Prophylactic treatment of very premature infants with human surfactant. N Engl J Med 315: 785–790PubMedCrossRefGoogle Scholar
  8. Raju TNK, Vidyasgar D, Bhat R (1987) Double-blind controlled trial of single-dose treatment with bovine surfactant in severe hyaline membrane disease. Lancet 1: 651–656PubMedCrossRefGoogle Scholar
  9. Stewart AR, Finer NN, Peters KL (1981) Effects of alterations of inspiratory and expiratory pressure and inspiratory/expiratory ratios on mean airway pressure, blood gases and intracranial pressure. Pediatrics 67: 474–481PubMedGoogle Scholar
  10. Thiebault DW, Beatty EC, Hall RT et al (1985) Neonatal pulmonary hypoplasia with premature rupture of fetal membranes and oligolhydramnios. J Pediatr 107: 273–277CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • T. A. Clarke
  • S. Gormally
  • A. Bergin
  • M. King
  • T. G. Matthews

There are no affiliations available

Personalised recommendations